Related references
Note: Only part of the references are listed.Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies
Hong Pan et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not Women
Yu-Heng Vivian Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
Mohammed-Salleh M. Ardawi et al.
BONE (2013)
Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women With Fragility Fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Ernesto Canalis
NATURE REVIEWS ENDOCRINOLOGY (2013)
Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database
Rohini K. Hernandez et al.
ACTA ORTHOPAEDICA (2012)
Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus
Laura A. G. Armas et al.
BONE (2012)
FRAX underestimates fracture risk in patients with diabetes
Lora M. Giangregorio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus
J. S. Manavalan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Understanding the Skeletal Pathology of Type 1 and 2 Diabetes Mellitus
Laura R. McCabe et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2011)
Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes
T. Neumann et al.
DIABETIC MEDICINE (2011)
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Ann V. Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Parathyroid Hormone Stimulates Circulating Osteogenic Cells in Hypoparathyroidism
M. R. Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus
I. Kanazawa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells
Masaaki Inaba et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone Mass and Strength in Older Men With Type 2 Diabetes: The Osteoporotic Fractures in Men Study
Moira A. Petit et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone Metabolic Abnormalities Associated with Well-Controlled Type 1 Diabetes (IDDM) in Young Adult Women: A Disease Complication Often Ignored or Neglected
Priscilla G. Masse et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2010)
Predictors of Outcome Following Hip Fracture Rehabilitation
Jennifer Semel et al.
PM&R (2010)
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Yoon K. Loke et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate
S. Y. Tang et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Pentosidine effects on human osteoblasts in vitro
Roberta Sanguineti et al.
MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES (2008)
A Bone Structural Basis for Fracture Risk in Diabetes
L. Joseph Melton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A national perspective of Medicare expenditures for elderly veterans with hip fractures
Elizabeth Bass et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2008)
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Biphasic fracture risk in diabetes: A population-based study
William D. Leslie et al.
BONE (2007)
Characterization of circulating osteoblast lineage cells in humans
Guiti Z. Eghbali-Fatourechi et al.
BONE (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Type 2 diabetes mellitus in nursing home patients:: Effects on bone turnover, bone mass, and fracture risk
Harald Dobnig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study
Denise E. Bonds et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone
P Garnero et al.
BONE (2006)
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
II de Liefde et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone
S Kume et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice
S Botolin et al.
ENDOCRINOLOGY (2005)
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
CG Schalkwijk et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
AD McCarthy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Octreotide abolishes the acute decrease in bone turnover in response to oral glucose
JA Clowes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Diabetes mellitus: Does it affect bone?
AV Schwartz
CALCIFIED TISSUE INTERNATIONAL (2003)
Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development
AD McCarthy et al.
ACTA DIABETOLOGICA (2001)
Share Paper
